Eton Pharmaceuticals Inc (ETON)


Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Eton Pharmaceuticals Inc chart...

About the Company

eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.

Exchange

NASDAQ

Website

etonpharma.com

$34M

Total Revenue

39

Employees

$89M

Market Capitalization

-97.88

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ETON News

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

4d ago, source:

Revenue Growth: Q4 product sales and royalty revenue surged by 109% year-over-year to $7.3 million. Positive Cash Flow: ETON ...

Eton Pharmaceuticals Inc

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

4d ago, source: Business Insider

March 14, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for ...

Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript

4d ago, source: Seeking Alpha

Good afternoon, and welcome to Eton Pharmaceuticals' Fourth Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks ...

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

4d ago, source: Zacks.com on MSN

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.04 per share a year ago.

Q4 2023 Eton Pharmaceuticals Inc Earnings Call

3d ago, source:

Sean Brynjelsen; CEO; Eton Pharmaceuticals, Inc. James Gruber; CFO; Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript

3d ago, source: InvestingChannel on MSN

Q4 2023 Earnings Call March 14, 2024 Eton Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...